Miguel de los Rios to Spoke at June 13 Science Commencement

Miguel de los Rios is a passionate entrepreneur focused on building and developing novel therapeutics to satisfy unmet needs in human medicine. He received his Ph.D. In biophysical chemistry and a BS in cell biology, both at UCSB. Currently, Miguel is Vice President of Research and Development at Sevion Therapeutics (formerly Fabrus, Inc.), a clinical stage therapeutics company with a focus in oncology and autoimmune disorders. Previously, he founded Chimeros, Inc., a venture-backed biologics therapeutic company in 2003 while working to complete his Ph.D. at UCSB. At Chimeros, he served as both the Chief Executive Officer as well as the Chief Scientific Officer from 2003-2011, and was the inventor of the company’s core technologies. He continues to build and help launch companies whose missions are to radically disrupt current medical approaches. He also advises several start-up biotechnology companies and venture capital firms. Miguel is lead author or inventor on 50 publications, patents and patent applications.

Miguel de los Rios

News Date: 

Saturday, June 13, 2015